Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Sale of 523 ANTX shares, $3.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | AN2 Therapeutics, Inc. (ANTX) | Sale | 523 | $3.2K |
| Sep 8, 2026 | AN2 Therapeutics, Inc. (ANTX) | Sale | 2,877 | $17.5K |
| Aug 19, 2026 | AN2 Therapeutics, Inc. (ANTX) | Sale | 16,696 | $100.3K |
| Mar 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 20,724 | n/a |
| Feb 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 20,400 | n/a |
| May 23, 2025 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 19,111 | n/a |
| Dec 23, 2024 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 9,077 | n/a |
| Dec 11, 2024 | AN2 Therapeutics, Inc. (ANTX) | Purchase | 12,711 | $18.4K |
| Nov 28, 2024 | AN2 Therapeutics, Inc. (ANTX) | Purchase | 12,500 | $17.4K |
| Nov 21, 2024 | AN2 Therapeutics, Inc. (ANTX) | Purchase | 75,000 | $77.5K |